Takeda Receives Approval from European Commission for FRUZAQLA in Previously Treated Metastatic Colorectal Cancer
Author of the article:Published Jun 21, 2024 • 14 minute read− Approval Based on Results from Positive, Global, Phase 3 ...
Read moreDetails
